Colinz Laboratories Limited (BOM:531210)
India · Delayed Price · Currency is INR 82.94
+0.37 (0.45%)
At close: Jul 28, 2026
Colinz Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 209 | 112 | 182 | 95 | 160 | 108 | |
Market Cap Growth | 72.32% | -38.57% | 92.92% | -40.87% | 48.62% | 209.87% |
Enterprise Value | 128 | 44 | 110 | 36 | 113 | 64 |
Last Close Price | 82.94 | 44.50 | 72.44 | 37.55 | 35.00 | 23.55 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 40.66 | 21.79 | 36.75 | 19.43 | 34.98 | 31.73 |
PS Ratio | 3.41 | 1.83 | 2.80 | 1.35 | 2.24 | 1.54 |
PB Ratio | 2.08 | 1.12 | 1.93 | 1.06 | 1.97 | 1.40 |
P/TBV Ratio | 2.08 | 1.12 | 1.93 | 1.06 | 1.97 | 1.40 |
P/FCF Ratio | 8.22 | 4.41 | - | 9.14 | 39.71 | 25.06 |
P/OCF Ratio | 8.22 | 4.41 | - | 9.14 | 39.71 | 23.05 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.08 | 0.73 | 1.69 | 0.51 | 1.58 | 0.91 |
EV/EBITDA Ratio | 31.29 | 10.92 | 22.26 | 6.58 | 17.83 | 10.88 |
EV/EBIT Ratio | 50.75 | 17.71 | 30.28 | 8.66 | 22.39 | 16.57 |
EV/FCF Ratio | 5.02 | 1.75 | - | 3.45 | 27.99 | 14.85 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.04 | 0.04 | 0.07 | 0.06 | 0.03 | 0.06 |
Debt / EBITDA Ratio | 0.96 | 0.96 | 1.29 | 1.05 | 0.43 | 0.83 |
Debt / FCF Ratio | 0.15 | 0.15 | - | 0.55 | 0.68 | 1.13 |
Net Debt / Equity Ratio | -0.81 | -0.81 | -0.52 | -0.72 | -0.67 | -0.61 |
Net Debt / EBITDA Ratio | -19.97 | -19.97 | -9.92 | -11.85 | -8.62 | -8.05 |
Net Debt / FCF Ratio | -3.20 | -3.20 | 2.86 | -6.21 | -13.54 | -10.99 |
Asset Turnover | 0.50 | 0.50 | 0.56 | 0.65 | 0.71 | 0.70 |
Inventory Turnover | 2.30 | 2.30 | 2.63 | 2.74 | 2.57 | 2.19 |
Quick Ratio | 3.65 | 3.65 | 2.87 | 3.60 | 3.64 | 3.24 |
Current Ratio | 3.93 | 3.93 | 4.17 | 4.00 | 4.15 | 3.72 |
Return on Equity (ROE) | 5.27% | 5.27% | 5.39% | 5.70% | 5.78% | 4.53% |
Return on Assets (ROA) | 1.28% | 1.28% | 1.96% | 2.39% | 3.12% | 2.40% |
Return on Invested Capital (ROIC) | 7.47% | 5.80% | 8.24% | 11.87% | 13.60% | 8.28% |
Return on Capital Employed (ROCE) | 2.50% | 2.50% | 3.80% | 4.50% | 6.00% | 4.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.46% | 4.59% | 2.72% | 5.15% | 2.86% | 3.15% |
FCF Yield | 12.16% | 22.67% | -9.40% | 10.94% | 2.52% | 3.99% |
Buyback Yield / Dilution | -0.05% | -0.05% | 0.04% | -0.34% | 45.19% | 0.61% |